Webinar Title: Effectiveness of Teriparatide in Preventing and Healing Osteoporotic Fracture 
Date: Wednesday, May 16, 2018
Time: 7:00pm - 8:15pm EST
Service: ARJR

Here is registration link for this webinar:

Register here

OVERVIEW  

Teriparatide, recombinant human parathyroid hormone (PTH), has been used as an adjunctive treatment to prevent and promote healing of fractures and nonunions in people with osteoporosis. The effectiveness of teriparatide in this setting is not well reported. As a result, the indications for administering teriparatide are not well established.

HSS Journal® is presenting a one-hour live-streaming webinar based on two articles on this topic published in the journal. The first, Bone Mineral Density Response from Teriparatide in Patients with Osteoporosis, was published in July 2017. This study, a retrospective chart review, examined the effects of 18 to 24 months of teriparatide therapy on bone mineral density in patients with osteoporosis. The findings and their implications will be presented by one of the authors, Dr. Richard Bockman from Hospital for Special Surgery. 

The second article, Recent Advances Toward the Clinical Application of PTH (1-34) in Fracture Healing, was published in September 2009. This review article focused on teriparatide’s role in the healing of bone fracture in osteoporotic patients. One of the authors, Dr. Joseph Lane of HSS, will discuss his article, as well as two more recent articles published elsewhere that expand on what is known about the efficacy of teriparatide in osteoporotic fracture prevention and healing. 

TARGET AUDIENCE 

This activity is targeted to orthopaedic surgeons, rheumatologists, family medicine physicians, endocrinologists, and internists. Physiatrists, physical therapists, physician assistants, nurse practitioners rehabilitation therapists, residents, fellows, and medical students may also benefit from attending this activity.

ACCREDITATION AND CREDIT DESIGNATION

Hospital for Special Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Hospital for Special Surgery designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AGENDA

Moderator Charles N. Cornell, MD

7:00pm Introduction
Charles N. Cornell, MD

7:05pm Bone Mineral Density Response from Teriparatide in Patients with Osteoporosis
Richard S. Bockman, MD

7:30pm Recent Advances Toward the Clinical Application of Teriparatide in Fracture Healing
Joseph M. Lane, MD

7:50 pm  Discussion on Updates
Joseph M. Lane, MD
Richard S. Bockman, MD

8:00 pm Discussion/Q&A
Joseph M. Lane, MD
Richard S. Bockman, MD

8:15pm Adjourn

FACULTY

Richard S. Bockman, MD
Charles N. Cornell, MD
Joseph M. Lane, MD

Faculty and agenda are subject to change.